• Je něco špatně v tomto záznamu ?

RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia

E. Papaemmanuil, I. Rapado, Y. Li, NE. Potter, DC. Wedge, J. Tubio, LB. Alexandrov, P. Van Loo, SL. Cooke, J. Marshall, I. Martincorena, J. Hinton, G. Gundem, FW. van Delft, S. Nik-Zainal, DR. Jones, M. Ramakrishna, I. Titley, L. Stebbings, C....

. 2014 ; 46 (2) : 116-25.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14050702
E-zdroje Online Plný text

NLK ProQuest Central od 2000-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1998-06-01 do 2015-11-30
Health & Medicine (ProQuest) od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2000-01-01 do Před 1 rokem

The ETV6-RUNX1 fusion gene, found in 25% of childhood acute lymphoblastic leukemia (ALL) cases, is acquired in utero but requires additional somatic mutations for overt leukemia. We used exome and low-coverage whole-genome sequencing to characterize secondary events associated with leukemic transformation. RAG-mediated deletions emerge as the dominant mutational process, characterized by recombination signal sequence motifs near breakpoints, incorporation of non-templated sequence at junctions, ∼30-fold enrichment at promoters and enhancers of genes actively transcribed in B cell development and an unexpectedly high ratio of recurrent to non-recurrent structural variants. Single-cell tracking shows that this mechanism is active throughout leukemic evolution, with evidence of localized clustering and reiterated deletions. Integration of data on point mutations and rearrangements identifies ATF7IP and MGA as two new tumor-suppressor genes in ALL. Thus, a remarkably parsimonious mutational process transforms ETV6-RUNX1-positive lymphoblasts, targeting the promoters, enhancers and first exons of genes that normally regulate B cell differentiation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14050702
003      
CZ-PrNML
005      
20140411103920.0
007      
ta
008      
140401s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/ng.2874 $2 doi
035    __
$a (PubMed)24413735
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Papaemmanuil, Elli
245    10
$a RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia / $c E. Papaemmanuil, I. Rapado, Y. Li, NE. Potter, DC. Wedge, J. Tubio, LB. Alexandrov, P. Van Loo, SL. Cooke, J. Marshall, I. Martincorena, J. Hinton, G. Gundem, FW. van Delft, S. Nik-Zainal, DR. Jones, M. Ramakrishna, I. Titley, L. Stebbings, C. Leroy, A. Menzies, J. Gamble, B. Robinson, L. Mudie, K. Raine, S. O'Meara, JW. Teague, AP. Butler, G. Cazzaniga, A. Biondi, J. Zuna, H. Kempski, M. Muschen, AM. Ford, MR. Stratton, M. Greaves, PJ. Campbell,
520    9_
$a The ETV6-RUNX1 fusion gene, found in 25% of childhood acute lymphoblastic leukemia (ALL) cases, is acquired in utero but requires additional somatic mutations for overt leukemia. We used exome and low-coverage whole-genome sequencing to characterize secondary events associated with leukemic transformation. RAG-mediated deletions emerge as the dominant mutational process, characterized by recombination signal sequence motifs near breakpoints, incorporation of non-templated sequence at junctions, ∼30-fold enrichment at promoters and enhancers of genes actively transcribed in B cell development and an unexpectedly high ratio of recurrent to non-recurrent structural variants. Single-cell tracking shows that this mechanism is active throughout leukemic evolution, with evidence of localized clustering and reiterated deletions. Integration of data on point mutations and rearrangements identifies ATF7IP and MGA as two new tumor-suppressor genes in ALL. Thus, a remarkably parsimonious mutational process transforms ETV6-RUNX1-positive lymphoblasts, targeting the promoters, enhancers and first exons of genes that normally regulate B cell differentiation.
650    _2
$a sekvence nukleotidů $7 D001483
650    _2
$a transkripční faktory bHLH $x genetika $7 D051792
650    _2
$a protein PEBP2A2 $x genetika $7 D050676
650    _2
$a variabilita počtu kopií segmentů DNA $x genetika $7 D056915
650    _2
$a regulace genové exprese u nádorů $x genetika $7 D015972
650    _2
$a genová knihovna $7 D015723
650    _2
$a genová přestavba $x genetika $7 D015321
650    _2
$a tumor supresorové geny $7 D016147
650    12
$a genetická variace $7 D014644
650    _2
$a homeodoménové proteiny $x genetika $7 D018398
650    _2
$a lidé $7 D006801
650    _2
$a molekulární sekvence - údaje $7 D008969
650    _2
$a fúzní onkogenní proteiny $x genetika $7 D015514
650    _2
$a pre-B-buněčná leukemie $x genetika $7 D015452
650    _2
$a rekombinace genetická $x genetika $7 D011995
650    _2
$a sekvenční analýza DNA $7 D017422
650    _2
$a sekvenční delece $x genetika $7 D017384
650    _2
$a transkripční faktory $x genetika $7 D014157
650    _2
$a V(D)J rekombinace $x genetika $7 D060152
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rapado, Inmaculada $u -
700    1_
$a Li, Yilong $u -
700    1_
$a Potter, Nicola E $u -
700    1_
$a Wedge, David C $u -
700    1_
$a Tubio, Jose $u -
700    1_
$a Alexandrov, Ludmil B $u - $7 gn_A_00003957
700    1_
$a Van Loo, Peter $u -
700    1_
$a Cooke, Susanna L $u -
700    1_
$a Marshall, John $u -
700    1_
$a Martincorena, Inigo $u -
700    1_
$a Hinton, Jonathan $u -
700    1_
$a Gundem, Gunes $u -
700    1_
$a van Delft, Frederik W $u -
700    1_
$a Nik-Zainal, Serena $u -
700    1_
$a Jones, David R $u -
700    1_
$a Ramakrishna, Manasa $u -
700    1_
$a Titley, Ian $u -
700    1_
$a Stebbings, Lucy $u -
700    1_
$a Leroy, Catherine $u -
700    1_
$a Menzies, Andrew $u -
700    1_
$a Gamble, John $u -
700    1_
$a Robinson, Ben $u -
700    1_
$a Mudie, Laura $u -
700    1_
$a Raine, Keiran $u -
700    1_
$a O'Meara, Sarah $u -
700    1_
$a Teague, Jon W $u -
700    1_
$a Butler, Adam P $u -
700    1_
$a Cazzaniga, Giovanni $u -
700    1_
$a Biondi, Andrea $u -
700    1_
$a Zuna, Jan $u -
700    1_
$a Kempski, Helena $u -
700    1_
$a Muschen, Markus $u -
700    1_
$a Ford, Anthony M $u -
700    1_
$a Stratton, Michael R $u -
700    1_
$a Greaves, Mel $u -
700    1_
$a Campbell, Peter J $u -
773    0_
$w MED00003458 $t Nature genetics $x 1546-1718 $g Roč. 46, č. 2 (2014), s. 116-25
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24413735 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140401 $b ABA008
991    __
$a 20140411104011 $b ABA008
999    __
$a ok $b bmc $g 1017838 $s 849282
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 46 $c 2 $d 116-25 $i 1546-1718 $m Nature genetics $n Nat Genet $x MED00003458
LZP    __
$a Pubmed-20140401

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...